Reducing Heart Failure Medications When Your Heart Recovers
Part of Heart & circulation clinical trials.
This study tests whether patients whose heart failure has improved can safely reduce some of their medications. If your heart function has recovered significantly and stayed stable, this trial explores whether you can gradually lower doses of heart failure drugs while staying healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Previously diagnosed with heart failure with reduced ejection fraction (weak pumping)
- Heart has recovered: ejection fraction improved to 50% or higher and stayed normal for at least 6 months
- Currently taking at least 3 heart failure medications at full doses, unchanged for at least 6 months
- Recent blood test (NT-proBNP) shows your heart is stable
- No major heart events (heart attack, stroke, surgery) in the past 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether safely increasing the dose of standard heart failure medications can improve outcomes in people with a weak heart pump, while keeping a close eye on kidney function. It may be a good fit if you have heart failure with reduced ejection fraction and are not yet on the highest recommended doses of your medicines.
This trial tests whether it is safe to slowly reduce some heart failure medications for people whose heart function has improved to normal. It is for patients who once had a weak heart pump but now have recovered strength and are stable on multiple medicines.
This study tests whether patients whose heart function has fully recovered after surgery or a heart procedure can safely reduce or stop their heart failure medications. Researchers will carefully monitor whether gradually lowering these medicines is safe and maintains heart health.
This trial is testing whether people whose heart failure has improved (with better pumping strength) can safely stop taking some of their heart medications. It is for stable patients who have had significant improvement in their heart function from a low point.
This study looks at how well patients with heart failure who have reduced pumping function do when they receive the standard recommended medications. It aims to see short-term improvements in heart function and symptoms.
This study looks for markers in the blood that can predict whether the heart's pumping function improves in people with chronic heart failure. It may help doctors understand which treatments work best for each person.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.